Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
0.2716
-0.0034 (-1.24%)
At close: Jul 3, 2025, 1:00 PM
0.2764
+0.0048 (1.77%)
After-hours: Jul 3, 2025, 4:59 PM EDT
Biodesix Market Cap
Biodesix has a market cap or net worth of $39.81 million as of July 3, 2025. Its market cap has decreased by -82.96% in one year.
Market Cap
39.81M
Enterprise Value
86.07M
1-Year Change
-82.96%
Ranking
Category
Stock Price
$0.27
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $39.81M, a decrease of -88.16%. That is a compound annual growth rate of -36.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 39.81M | -82.11% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | 535.07M | 59.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |